Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.68), $0.10 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $45.6 million versus the consensus estimate of $39.02 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.